2005 Annual Meeting | Vascular Dementia and Vascular Cognitive Impairment: Advances in Diagnosis and Treatment

Date Sunday 04/10/05

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Gustavo C. Roman, MD, FAAN

Topic(s) Cognitive Neurology/Neurologic Disorders Presenting with Psychiatric Symptoms, Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants should become familiar with the evolution of concepts and clinical spectrum of vascular dementia and vascular cognitive impairment; the strengths and limitations of the diagnostic criteria for vascular dementia and vascular cognitive impairment; and new data about risk factor modifying and cognitive enhancing treatments for vascular dementia.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:45 AM - 07:30 AM		Introduction, Definitions and Pathophysiology Gustavo C. Roman, MD, FAAN
06:45 AM - 08:30 AM		Breakfast
07:30 AM - 08:15 AM		Clinical Aspects, Treatment and Prevention Stephen P. Salloway, MD, MS
08:15 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Gustavo C. Roman, MD, FAAN	The institution of Dr. Roman has received research support from Brain Chamistry Labs.
Stephen P. Salloway, MD, MS	Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NovoNordisk. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurophet. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kisbee. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CognitionRX. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck.

��ɫ��

��ɫ��